IRIS Accounts Production v24.2.0.383 11273286 Board of Directors Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh112732862023-03-31112732862024-03-31112732862023-04-012024-03-31112732862022-03-31112732862022-04-012023-03-31112732862023-03-3111273286ns15:EnglandWales2023-04-012024-03-3111273286ns14:PoundSterling2023-04-012024-03-3111273286ns10:Director12023-04-012024-03-3111273286ns10:Director22023-04-012024-03-3111273286ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3111273286ns10:SmallEntities2023-04-012024-03-3111273286ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3111273286ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3111273286ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111273286ns10:AbridgedAccounts2023-04-012024-03-3111273286ns10:OrdinaryShareClass12023-04-012024-03-3111273286ns10:OrdinaryShareClass22023-04-012024-03-3111273286ns10:RegisteredOffice2023-04-012024-03-3111273286ns5:CurrentFinancialInstruments2024-03-3111273286ns5:CurrentFinancialInstruments2023-03-3111273286ns5:Non-currentFinancialInstruments2024-03-3111273286ns5:Non-currentFinancialInstruments2023-03-3111273286ns5:ShareCapital2024-03-3111273286ns5:ShareCapital2023-03-3111273286ns5:RetainedEarningsAccumulatedLosses2024-03-3111273286ns5:RetainedEarningsAccumulatedLosses2023-03-3111273286ns10:OrdinaryShareClass12024-03-3111273286ns10:OrdinaryShareClass12022-04-012023-03-3111273286ns10:OrdinaryShareClass22024-03-3111273286ns10:OrdinaryShareClass22022-04-012023-03-31
REGISTERED NUMBER: 11273286 (England and Wales)














Unaudited Financial Statements

for the Year Ended 31st March 2024

for

Flex Neuro Limited

Flex Neuro Limited (Registered number: 11273286)






Contents of the Financial Statements
for the year ended 31st March 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 6

Flex Neuro Limited

Company Information
for the year ended 31st March 2024







DIRECTORS: M D Booth
A M Chester



REGISTERED OFFICE: Shed A
K3 Business Park
Clough Road
Hull
East Yorkshire
HU5 1SN



REGISTERED NUMBER: 11273286 (England and Wales)



ACCOUNTANTS: Sadofskys
Chartered Accountants
Princes House
Wright Street
Hull
East Yorkshire
HU2 8HX



BANKERS: Barclays Bank plc
Humber & Lincolnshire Team
4th Floor
2 Humber Quays
Hull
HU1 2BN

Flex Neuro Limited (Registered number: 11273286)

Abridged Balance Sheet
31st March 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 81,594 87,536
Cash at bank and in hand 238,332 204,832
319,926 292,368
CREDITORS
Amounts falling due within one year 16,064 7,876
NET CURRENT ASSETS 303,862 284,492
TOTAL ASSETS LESS CURRENT
LIABILITIES

303,862

284,492

CREDITORS
Amounts falling due after more than one
year

13,638

20,333
NET ASSETS 290,224 264,159

CAPITAL AND RESERVES
Called up share capital 4 2 2
Retained earnings 290,222 264,157
SHAREHOLDERS' FUNDS 290,224 264,159

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Flex Neuro Limited (Registered number: 11273286)

Abridged Balance Sheet - continued
31st March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31st March 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21st August 2024 and were signed on its behalf by:




A M Chester - Director



M D Booth - Director


Flex Neuro Limited (Registered number: 11273286)

Notes to the Financial Statements
for the year ended 31st March 2024

1. STATUTORY INFORMATION

Flex Neuro Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Government grants
Government grants are recognised using the accruals model. Grants of a revenue nature are credited to income so as to match them with the expenditure to which they relate.

Grants in respect of capital expenditure are credited to a deferred income account and are released to profit over the expected useful lives of the assets to which they relate.

A grant that becomes receivable as compensation for expenses or losses already incurred, or for the purpose of giving immediate financial support to the company with no future related costs, is credited to income in the period in which it becomes receivable.

Flex Neuro Limited (Registered number: 11273286)

Notes to the Financial Statements - continued
for the year ended 31st March 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary A £1 1 1
1 Ordinary B £1 1 1
2 2

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Flex Neuro Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Flex Neuro Limited for the year ended 31st March 2024 which comprise the Income Statement, Abridged Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Flex Neuro Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Flex Neuro Limited and state those matters that we have agreed to state to the Board of Directors of Flex Neuro Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Flex Neuro Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Flex Neuro Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Flex Neuro Limited. You consider that Flex Neuro Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Flex Neuro Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Sadofskys
Chartered Accountants
Princes House
Wright Street
Hull
East Yorkshire
HU2 8HX


21st August 2024